Please Wait
Applying Filters...
menu
    • menu
    PharmaCompass Sponsored Ads

    Virtual Booth

    Contact Supplier

    Kewpie is your partner for Sodium Hyaluronate & Hyaluronic Acid// CEP, USDMF, KDMF & JDMF registered.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2025-03-24

    Virtual Booth

    Contact Supplier

    Centrient is a leading manufacturer of Beta-Lactam Antibiotics and a provider of next-generation Statins and Antifungals.

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2025-03-17

    Virtual Booth

    Contact Supplier

    Menu

    Cladribine

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    INTERMEDIATES

    FINISHED DOSAGE FORMULATIONS

    RELATED EXCIPIENT COMPANIES

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    PATENTS & EXCLUSIVITIES

    REF. STANDARDS & IMPURITIES

    PharmaCompass
    $ API Ref.Price (USD/KG) : 87,945Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Merck Doses First Patient In Phase III Cladribine Study For gMG
    Merck Doses First Patient In Phase III Cladribine Study For gMG

    30 Aug 2024

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20240829780819/en

    BUSINESSWIRE
    30 Aug 2024
    Share Share
    BioNxt Signs Statement For Cladribine ODF Development With CRO
    BioNxt Signs Statement For Cladribine ODF Development With CRO

    17 Jul 2024

    // ACCESSWIRE

    https://www.accesswire.com/viewarticle.aspx?id=889574&lang=en

    ACCESSWIRE
    17 Jul 2024
    Share Share
    BioNxt Solutions Announces ODF Cladribine Update and Financing
    BioNxt Solutions Announces ODF Cladribine Update and Financing

    25 Apr 2024

    // ACCESSWIRE

    https://www.accesswire.com/856964/bionxt-solutions-announces-odf-cladribine-update-and-financing

    ACCESSWIRE
    25 Apr 2024
    Share Share
    BioNxt Reports Commercialization of ODF Cladribine Product for MS Next Steps
    BioNxt Reports Commercialization of ODF Cladribine Product for MS Next Steps

    18 Mar 2024

    // ACCESSWIRE

    https://www.accesswire.com/843970/bionxt-reports-commercialization-of-odf-cladribine-product-for-ms-next-steps

    ACCESSWIRE
    18 Mar 2024
    Share Share
    EMD Serono Presents New MAVENCLAD® (Cladribine) Tablets Data
    EMD Serono Presents New MAVENCLAD® (Cladribine) Tablets Data

    10 Oct 2023

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20231009660910/en

    BUSINESSWIRE
    10 Oct 2023
    Share Share
    Merck Presents New MAVENCLAD® (Cladribine Tablets) Data
    Merck Presents New MAVENCLAD® (Cladribine Tablets) Data

    10 Oct 2023

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20231009626393/en

    BUSINESSWIRE
    10 Oct 2023
    Share Share